ST. LOUIS, March 05, 2025--(BUSINESS WIRE)--Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent Medicare coverage of the ...
Cofactor Genomics Announces the Expansion of OncoPrism into Colorectal, Breast, Bladder, and Kidney Cancer Platform Now Covering Majority of Patients with Solid-tumor Cancers Cofactor Genomics ...